← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2007Last known activity
Aug 23, 2023
Timeline
2000s
- Jan 1, 2000
CrystalGenomics, Inc.— Founded
2010s
- Dec 1, 2015
BTO Pharm. Co., Ltd.— Acquired
Drugs by trial phase (18 distinct, 19 trials)
Phase 3 (2 own, 1 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (24)
- NCT05841472Lead sponsorPhase 2Aug 23, 2023
- NCT05345912Lead sponsorPhase 1Dec 16, 2019
- NCT05370716Lead sponsorPhase 1Nov 11, 2019
- NCT05393856Lead sponsorPhase 1Sep 23, 2019
- NCT03774355Lead sponsorPhase 1Dec 17, 2018
- NCT03775629Lead sponsorPhase 1Dec 1, 2018
- NCT02737462Lead sponsorPhase 1/Phase 2Jun 1, 2016
- NCT02737228Lead sponsorPhase 1/Phase 2Mar 1, 2016
- NCT01765296Lead sponsorPhase 3Mar 1, 2013
- NCT01765296Study directorPhase 3Mar 1, 2013
- NCT01593761Lead sponsorPhase 2Jun 1, 2012
- NCT01341405Lead sponsorPhase 2Apr 1, 2011
- NCT01226407Lead sponsorPhase 1Sep 1, 2010
- NCT01154790Lead sponsorPhase 1Jun 1, 2010
- NCT01154790Study directorPhase 1Jun 1, 2010
Details
- Founded
- Seongnam, KR Jan 1, 2000
- Last known activity
- Aug 23, 2023